Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Ingevity | NGVT | Jan 14, 2025 | 40.08 | +1.01 |
Ingles Markets A | IMKTA | Jan 14, 2025 | 63.79 | -0.65 |
Ingram Micro Holding Corp | INGM | Jan 14, 2025 | 20.43 | 0.00 |
Ingredion | INGR | Jan 14, 2025 | 132.76 | +0.71 |
Inhibikase Therapeutics | IKT | Jan 14, 2025 | 2.66 | 0.00 |
Inhibrx Biosciences | INBX | Jan 14, 2025 | 12.74 | -6.60 |
INLIF | INLF | Jan 14, 2025 | 4.82 | 0.00 |
InMed Pharmaceuticals | INM | Jan 14, 2025 | 4.08 | -3.32 |
InMode | INMD | Jan 14, 2025 | 16.07 | +0.63 |
INmune Bio | INMB | Jan 14, 2025 | 5.96 | -8.95 |
Innate Pharma ADR | IPHA | Jan 14, 2025 | 1.78 | -1.92 |
Inno Holdings | INHD | Jan 14, 2025 | 5.30 | +2.91 |
Innodata | INOD | Jan 14, 2025 | 33.95 | +1.56 |
Innospec | IOSP | Jan 14, 2025 | 111.44 | +3.26 |
InnovAge | INNV | Jan 14, 2025 | 3.69 | +1.93 |
Innovate | VATE | Jan 14, 2025 | 4.78 | +0.84 |
Innovation Beverage Group | IBG | Jan 14, 2025 | 1.04 | +16.84 |
Innovative Eyewear | LUCY | Jan 14, 2025 | 5.73 | +2.69 |
Innovative Industrial Properties | IIPR | Jan 14, 2025 | 66.32 | +1.98 |
Innovative Industrial Properties A Pref | IIPR-A | Jan 14, 2025 | 25.07 | -0.16 |
Innovative Solutions and Support | ISSC | Jan 14, 2025 | 8.86 | +4.36 |
Innovex International | INVX | Jan 14, 2025 | 16.62 | +5.52 |
Innovid | CTV | Jan 14, 2025 | 3.03 | +0.33 |
Innoviva | INVA | Jan 14, 2025 | 17.68 | +0.68 |
Innoviz Technologies | INVZ | Jan 14, 2025 | 1.43 | -11.18 |
InnSuites Hospitality | IHT | Jan 14, 2025 | 2.47 | -1.20 |
Innventure | INV | Jan 14, 2025 | 11.62 | +1.57 |
Inogen | INGN | Jan 14, 2025 | 10.62 | +2.81 |
Inotiv | NOTV | Jan 14, 2025 | 4.22 | 0.00 |
Inovio Pharmaceuticals | INO | Jan 14, 2025 | 1.87 | -1.58 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.